206 related articles for article (PubMed ID: 32647130)
1. Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus.
Rösener NS; Gremer L; Wördehoff MM; Kupreichyk T; Etzkorn M; Neudecker P; Hoyer W
Commun Biol; 2020 Jul; 3(1):365. PubMed ID: 32647130
[TBL] [Abstract][Full Text] [Related]
2. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
[TBL] [Abstract][Full Text] [Related]
3. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
[TBL] [Abstract][Full Text] [Related]
4. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
Madhu P; Mukhopadhyay S
ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343
[TBL] [Abstract][Full Text] [Related]
5. The Stimulatory Effects of Intracellular α-Synuclein on Synaptic Transmission Are Attenuated by 2-Octahydroisoquinolin-2(1H)-ylethanamine.
Ramirez AE; Fernández-Pérez EJ; Olivos N; Burgos CF; Boopathi S; Armijo-Weingart L; Pacheco CR; González W; Aguayo LG
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948050
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
[TBL] [Abstract][Full Text] [Related]
7. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
8. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.
Saijo E; Groveman BR; Kraus A; Metrick M; Orrù CD; Hughson AG; Caughey B
Methods Mol Biol; 2019; 1873():19-37. PubMed ID: 30341601
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
11. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
12. Small-Molecule-Induced Soluble Oligomers of α-Synuclein with Helical Structure.
Fonseca-Ornelas L; Schmidt C; Camacho-Zarco AR; Fernandez CO; Becker S; Zweckstetter M
Chemistry; 2017 Sep; 23(53):13010-13014. PubMed ID: 28763125
[TBL] [Abstract][Full Text] [Related]
13. Sleep inhibition induced by amyloid-β oligomers is mediated by the cellular prion protein.
Del Gallo F; Bianchi S; Bertani I; Messa M; Colombo L; Balducci C; Salmona M; Imeri L; Chiesa R
J Sleep Res; 2021 Jun; 30(3):e13187. PubMed ID: 32902030
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.
Zou WQ; Xiao X; Yuan J; Puoti G; Fujioka H; Wang X; Richardson S; Zhou X; Zou R; Li S; Zhu X; McGeer PL; McGeehan J; Kneale G; Rincon-Limas DE; Fernandez-Funez P; Lee HG; Smith MA; Petersen RB; Guo JP
J Biol Chem; 2011 Apr; 286(17):15095-105. PubMed ID: 21393248
[TBL] [Abstract][Full Text] [Related]
15. Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration.
Brás IC; Lopes LV; Outeiro TF
Mov Disord; 2018 Nov; 33(11):1675-1684. PubMed ID: 30423195
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Seeding Assay Using RT-QuIC.
Okuzumi A; Hatano T; Fukuhara T; Ueno S; Nukina N; Imai Y; Hattori N
Methods Mol Biol; 2021; 2322():3-16. PubMed ID: 34043187
[TBL] [Abstract][Full Text] [Related]
17. Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects.
La Vitola P; Beeg M; Balducci C; Santamaria G; Restelli E; Colombo L; Caldinelli L; Pollegioni L; Gobbi M; Chiesa R; Forloni G
Brain; 2019 Feb; 142(2):249-254. PubMed ID: 30601948
[TBL] [Abstract][Full Text] [Related]
18. Distinct effects of mutations on biophysical properties of human prion protein monomers and oligomers.
Yu Y; Yu Z; Zheng Z; Wang H; Wu X; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2016 Nov; 48(11):1016-1025. PubMed ID: 27649893
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein chaperone suppresses nucleation and amyloidogenesis of prion protein.
Shirasaka M; Kuwata K; Honda R
Biochem Biophys Res Commun; 2020 Jan; 521(1):259-264. PubMed ID: 31635805
[TBL] [Abstract][Full Text] [Related]
20. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.
Drew SC
Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
